Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs.
Dumitru CA, Sandalcioglu IE, Karsak M. Dumitru CA, et al. Front Mol Neurosci. 2018 May 16;11:159. doi: 10.3389/fnmol.2018.00159. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29867351 Free PMC article. Review.
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.
Schiffgens S, Wilkens L, Brandes AA, Meier T, Franceschi E, Ermani M, Hartmann C, Sandalcioglu IE, Dumitru CA. Schiffgens S, et al. Among authors: dumitru ca. Oncotarget. 2016 Aug 23;7(34):55169-55180. doi: 10.18632/oncotarget.10465. Oncotarget. 2016. PMID: 27409829 Free PMC article.
Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma.
Dumitru CA, Bankfalvi A, Gu X, Eberhardt WE, Zeidler R, Lang S, Brandau S. Dumitru CA, et al. Front Immunol. 2013 Feb 18;4:33. doi: 10.3389/fimmu.2013.00033. eCollection 2013. Front Immunol. 2013. PMID: 23423155 Free PMC article.
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
Neyazi B, Tanrikulu L, Wilkens L, Hartmann C, Stein KP, Dumitru CA, Sandalcioglu IE. Neyazi B, et al. Among authors: dumitru ca. World Neurosurg. 2017 Jun;102:79-84. doi: 10.1016/j.wneu.2017.02.116. Epub 2017 Mar 6. World Neurosurg. 2017. PMID: 28279775
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.
Beyer U, Brand F, Martens H, Weder J, Christians A, Elyan N, Hentschel B, Westphal M, Schackert G, Pietsch T, Hong B, Krauss JK, Samii A, Raab P, Das A, Dumitru CA, Sandalcioglu IE, Hakenberg OW, Erbersdobler A, Lehmann U, Reifenberger G, Weller M, Reijns MAM, Preller M, Wiese B, Hartmann C, Weber RG. Beyer U, et al. Among authors: dumitru ca. Acta Neuropathol. 2017 Dec;134(6):905-922. doi: 10.1007/s00401-017-1774-y. Epub 2017 Oct 13. Acta Neuropathol. 2017. PMID: 29030706 Free article.
Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ, Westerkamp AM, Kansy BA, Bruderek K, Dissmann PA, Dumitru CA, Lang S, Jackson EK, Brandau S. Schuler PJ, et al. Among authors: dumitru ca. Immunobiology. 2017 Jan;222(1):66-74. doi: 10.1016/j.imbio.2016.01.013. Epub 2016 Jan 30. Immunobiology. 2017. PMID: 26898925
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.
Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA. Weller P, et al. Eur J Cancer. 2014 May;50(7):1291-300. doi: 10.1016/j.ejca.2014.02.016. Epub 2014 Mar 11. Eur J Cancer. 2014. PMID: 24630394
AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.
Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S. Dumitru CA, et al. PLoS One. 2013;8(2):e56420. doi: 10.1371/journal.pone.0056420. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23409183 Free PMC article.
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology.
Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Dumitru CA, et al. Cancer Immunol Immunother. 2012 Aug;61(8):1155-67. doi: 10.1007/s00262-012-1294-5. Epub 2012 Jun 13. Cancer Immunol Immunother. 2012. PMID: 22692756 Review.
30 results
Jump to page